TreeWAS – Variant ID: rs10895275

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
E87.5 Hyperkalaemia	0.566	0.434	0.000
E87 Other disorders of fluid, electrolyte and acid-base balance	0.180	0.820	0.000
E87.0 Hyperosmolality and hypernatraemia	0.161	0.839	0.000
F10.1 Harmful use	0.152	0.848	0.000
F10 Mental and behavioural disorders due to use of alcohol	0.152	0.848	0.000
E87.6 Hypokalaemia	0.146	0.854	0.000
F10.4 Withdrawal state with delirium	0.142	0.858	0.000
F10.0 Acute intoxication	0.141	0.859	0.000
F10.2 Dependence syndrome	0.137	0.863	0.000
E87.4 Mixed disorder of acid-base balance	0.129	0.870	0.000
E87.3 Alkalosis	0.129	0.871	0.000
F10.9 Unspecified mental and behavioural disorder	0.123	0.877	0.000
F10.3 Withdrawal state	0.119	0.881	0.000
E87.7 Fluid overload	0.114	0.886	0.000
E87.8 Other disorders of electrolyte and fluid balance, not elsewhere classified	0.111	0.889	0.000
F10.8 Other mental and behavioural disorders	0.109	0.891	0.000
F10.7 Residual and late-onset psychotic disorder	0.109	0.891	0.000
F10.6 Amnesic syndrome	0.104	0.896	0.000
F10.5 Psychotic disorder	0.104	0.896	0.000
E83 Disorders of mineral metabolism	0.093	0.907	0.000
E83.1 Disorders of iron metabolism	0.092	0.908	0.000
E83.4 Disorders of magnesium metabolism	0.091	0.909	0.000
E70-E90 Metabolic disorders	0.090	0.910	0.000
E74 Other disorders of carbohydrate metabolism	0.080	0.920	0.000
E83.3 Disorders of phosphorus metabolism	0.077	0.923	0.000
E87.2 Acidosis	0.076	0.924	0.000
N35.9 Urethral stricture, unspecified	0.074	0.926	0.000
E74.3 Other disorders of intestinal carbohydrate absorption	0.073	0.927	0.000
E75 Disorders of sphingolipid metabolism and other lipid storage disorders	0.068	0.932	0.000
E83.9 Disorder of mineral metabolism, unspecified	0.067	0.933	0.000
E83.8 Other disorders of mineral metabolism	0.067	0.933	0.000
E83.2 Disorders of zinc metabolism	0.067	0.933	0.000
E83.0 Disorders of copper metabolism	0.067	0.933	0.000
E70 Disorders of aromatic amino-acid metabolism	0.067	0.933	0.000
E79 Disorders of purine and pyrimidine metabolism	0.065	0.935	0.000
E77 Disorders of glycoprotein metabolism	0.065	0.935	0.000
E76 Disorders of glycosaminoglycan metabolism	0.065	0.935	0.000
E72 Other disorders of amino-acid metabolism	0.065	0.935	0.000
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism	0.065	0.935	0.000
E90 Nutritional and metabolic disorders in diseases classified elsewhere	0.065	0.935	0.000
E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified	0.064	0.936	0.000
E84 Cystic fibrosis	0.060	0.940	0.000
E85 Amyloidosis	0.058	0.942	0.000
E74.9 Disorder of carbohydrate metabolism, unspecified	0.057	0.942	0.000
E74.8 Other specified disorders of carbohydrate metabolism	0.057	0.942	0.000
E74.4 Disorders of pyruvate metabolism and gluconeogenesis	0.057	0.942	0.000
E74.2 Disorders of galactose metabolism	0.057	0.942	0.000
E74.1 Disorders of fructose metabolism	0.057	0.942	0.000
E74.0 Glycogen storage disease	0.057	0.942	0.000
E75.2 Other sphingolipidosis	0.052	0.948	0.000
E89.2 Postprocedural hypoparathyroidism	0.051	0.949	0.000
E70.3 Albinism	0.050	0.950	0.000
E75.5 Other lipid storage disorders	0.049	0.951	0.000
E75.6 Lipid storage disorder, unspecified	0.049	0.951	0.000
E75.4 Neuronal ceroid lipofuscinosis	0.049	0.951	0.000
E75.3 Sphingolipidosis, unspecified	0.049	0.951	0.000
E75.1 Other gangliosidosis	0.049	0.951	0.000
E75.0 GM2 gangliosidosis	0.049	0.951	0.000
E70.9 Disorder of aromatic amino-acid metabolism, unspecified	0.048	0.952	0.000
E70.8 Other disorders of aromatic amino-acid metabolism	0.048	0.952	0.000
E70.2 Disorders of tyrosine metabolism	0.048	0.952	0.000
E70.1 Other hyperphenylalaninaemias	0.048	0.952	0.000
E70.0 Classical phenylketonuria	0.048	0.952	0.000
E73 Lactose intolerance	0.048	0.952	0.000
E89.4 Postprocedural ovarian failure	0.048	0.952	0.000
E79.0 Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease	0.048	0.952	0.000
E89.1 Postprocedural hypoinsulinaemia	0.047	0.953	0.000
E79.9 Disorder of purine and pyrimidine metabolism, unspecified	0.047	0.953	0.000
E79.8 Other disorders of purine and pyrimidine metabolism	0.047	0.953	0.000
E79.1 Lesch-Nyhan syndrome	0.047	0.953	0.000
E89.6 Postprocedural adrenocortical(-medullary) hypofunction	0.047	0.953	0.000
E71.3 Disorders of fatty-acid metabolism	0.047	0.953	0.000
E71.2 Disorder of branched-chain amino-acid metabolism, unspecified	0.047	0.953	0.000
E71.1 Other disorders of branched-chain amino-acid metabolism	0.047	0.953	0.000
E71.0 Maple-syrup-urine disease	0.047	0.953	0.000
E72.9 Disorder of amino-acid metabolism, unspecified	0.047	0.953	0.000
E72.8 Other specified disorders of amino-acid metabolism	0.047	0.953	0.000
E72.5 Disorders of glycine metabolism	0.047	0.953	0.000
E72.4 Disorders of ornithine metabolism	0.047	0.953	0.000
E72.3 Disorders of lysine and hydroxylysine metabolism	0.047	0.953	0.000
E72.2 Disorders of urea cycle metabolism	0.047	0.953	0.000
E72.1 Disorders of sulphur-bearing amino-acid metabolism	0.047	0.953	0.000
E72.0 Disorders of amino-acid transport	0.047	0.953	0.000
E76.9 Disorder of glucosaminoglycan metabolism, unspecified	0.047	0.953	0.000
E76.8 Other disorders of glucosaminoglycan metabolism	0.047	0.953	0.000
E76.3 Mucopolysaccharidosis, unspecified	0.047	0.953	0.000
E76.2 Other mucopolysaccharidoses	0.047	0.953	0.000
E76.1 Mucopolysaccharidosis, type II	0.047	0.953	0.000
E76.0 Mucopolysaccharidosis, type I	0.047	0.953	0.000
E77.9 Disorder of glycoprotein metabolism, unspecified	0.047	0.953	0.000
E77.8 Other disorders of glycoprotein metabolism	0.047	0.953	0.000
E77.1 Defects in glycoprotein degradation	0.047	0.953	0.000
E77.0 Defects in posttranslational modification of lysosomal enzymes	0.047	0.953	0.000
E89.9 Postprocedural endocrine and metabolic disorder, unspecified	0.046	0.954	0.000
E89.8 Other postprocedural endocrine and metabolic disorders	0.046	0.954	0.000
E89.5 Postprocedural testicular hypofunction	0.046	0.954	0.000
N35 Urethral stricture	0.046	0.954	0.000
E80 Disorders of porphyrin and bilirubin metabolism	0.045	0.955	0.000
E89.3 Postprocedural hypopituitarism	0.045	0.955	0.000
E85.9 Amyloidosis, unspecified	0.044	0.956	0.000
E84.8 Cystic fibrosis with other manifestations	0.043	0.956	0.000
E84.1 Cystic fibrosis with intestinal manifestations	0.043	0.956	0.000
E84.0 Cystic fibrosis with pulmonary manifestations	0.043	0.956	0.000
E88 Other metabolic disorders	0.043	0.957	0.000
E85.8 Other amyloidosis	0.041	0.958	0.000
E85.2 Heredofamilial amyloidosis, unspecified	0.041	0.958	0.000
E85.1 Neuropathic heredofamilial amyloidosis	0.041	0.958	0.000
E85.0 Nonneuropathic heredofamilial amyloidosis	0.041	0.958	0.000
N35.8 Other urethral stricture	0.040	0.960	0.000
E84.9 Cystic fibrosis, unspecified	0.039	0.961	0.000
E85.3 Secondary systemic amyloidosis	0.037	0.963	0.000
E80.1 Porphyria cutanea tarda	0.037	0.963	0.000
E85.4 Organ-limited amyloidosis	0.036	0.963	0.000
Z75.4 Unavailability and inaccessibility of other helping agencies	0.036	0.964	0.000
Z75 Problems related to medical facilities and other health care	0.035	0.965	0.000
Z75.5 Holiday relief care	0.035	0.965	0.000
E73.8 Other lactose intolerance	0.034	0.965	0.000
E73.1 Secondary lactase deficiency	0.034	0.965	0.000
E73.0 Congenital lactase deficiency	0.034	0.965	0.000
N35.1 Postinfective urethral stricture, not elsewhere classified	0.033	0.967	0.000
N35.0 Posttraumatic urethral stricture	0.033	0.967	0.000
F10-F19 Mental and behavioural disorders due to psychoactive substance use	0.033	0.967	0.000
E80.7 Disorder of bilirubin metabolism, unspecified	0.032	0.968	0.000
E80.5 Crigler-Najjar syndrome	0.032	0.968	0.000
E80.3 Defects of catalase and peroxydase	0.032	0.968	0.000
E80.0 Hereditary erythropoietic porphyria	0.032	0.968	0.000
E80.2 Other porphyria	0.032	0.968	0.000
E88.9 Metabolic disorder, unspecified	0.032	0.968	0.000
E89.0 Postprocedural hypothyroidism	0.032	0.968	0.000
E88.2 Lipomatosis, not elsewhere classified	0.031	0.969	0.000
E88.8 Other specified metabolic disorders	0.030	0.970	0.000
Z75.3 Unavailability and inaccessibility of health-care facilities	0.030	0.970	0.000
Z75.2 Other waiting period for investigation and treatment	0.030	0.970	0.000
E86 Volume depletion	0.029	0.971	0.000
E88.3 Tumour lysis syndrome	0.029	0.971	0.000
E88.1 Lipodystrophy, not elsewhere classified	0.029	0.971	0.000
Z75.0 Medical services not available in home	0.029	0.971	0.000
F12 Mental and behavioural disorders due to use of cannabinoids	0.026	0.974	0.000
Z75.1 Person awaiting admission to adequate facility elsewhere	0.026	0.974	0.000
E80.6 Other disorders of bilirubin metabolism	0.026	0.974	0.000
Z75.9 Unspecified problem related to medical facilities and other health care	0.026	0.974	0.000
F13 Mental and behavioural disorders due to use of sedatives or hypnotics	0.024	0.976	0.000
F18 Mental and behavioural disorders due to use of volatile solvents	0.024	0.976	0.000
F16 Mental and behavioural disorders due to use of hallucinogens	0.024	0.976	0.000
Z75.8 Other problems related to medical facilities and other health care	0.024	0.976	0.000
H43 Disorders of vitreous body	0.023	0.977	0.000
F15 Mental and behavioural disorders due to use of other stimulants, including caffeine	0.023	0.977	0.000
F14 Mental and behavioural disorders due to use of cocaine	0.023	0.977	0.000
H43.3 Other vitreous opacities	0.023	0.977	0.000
F11 Mental and behavioural disorders due to use of opioids	0.023	0.977	0.000
F19 Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances	0.022	0.978	0.000
H43.8 Other disorders of vitreous body	0.022	0.978	0.000
F12.0 Acute intoxication	0.021	0.979	0.000
E10 Insulin-dependent diabetes mellitus	0.021	0.979	0.000
E10.8 With unspecified complications	0.021	0.979	0.000
F12.2 Dependence syndrome	0.021	0.979	0.000
H43.9 Disorder of vitreous body, unspecified	0.020	0.979	0.000
F13.3 Withdrawal state	0.020	0.980	0.000
C80.9 Malignant neoplasm, unspecified	0.020	0.980	0.000
H43.2 Crystalline deposits in vitreous body	0.020	0.980	0.000
F12.5 Psychotic disorder	0.020	0.980	0.000
Z99.2 Dependence on renal dialysis	0.020	0.980	0.000
J44.0 Chronic obstructive pulmonary disease with acute lower respiratory infection	0.020	0.980	0.000
E10.2 With renal complications	0.019	0.981	0.000
F12.9 Unspecified mental and behavioural disorder	0.019	0.981	0.000
F12.8 Other mental and behavioural disorders	0.019	0.981	0.000
F12.7 Residual and late-onset psychotic disorder	0.019	0.981	0.000
F12.6 Amnesic syndrome	0.019	0.981	0.000
F12.4 Withdrawal state with delirium	0.019	0.981	0.000
F12.3 Withdrawal state	0.019	0.981	0.000
E10.9 Without complications	0.018	0.982	0.000
E73.9 Lactose intolerance, unspecified	0.017	0.982	0.001
H43-H45 Disorders of vitreous body and globe	0.018	0.982	0.000
E10.7 With multiple complications	0.018	0.982	0.000
M31.3 Wegener's granulomatosis	0.018	0.982	0.000
F13.9 Unspecified mental and behavioural disorder	0.017	0.982	0.000
F13.8 Other mental and behavioural disorders	0.017	0.982	0.000
F13.7 Residual and late-onset psychotic disorder	0.017	0.982	0.000
F13.6 Amnesic syndrome	0.017	0.982	0.000
F13.5 Psychotic disorder	0.017	0.982	0.000
F13.4 Withdrawal state with delirium	0.017	0.982	0.000
F13.1 Harmful use	0.017	0.982	0.000
F13.0 Acute intoxication	0.017	0.982	0.000
H44 Disorders of globe	0.017	0.983	0.000
F12.1 Harmful use	0.017	0.983	0.000
E87.1 Hypo-osmolality and hyponatraemia	0.017	0.983	0.000
E88.0 Disorders of plasma-protein metabolism, not elsewhere classified	0.017	0.983	0.000
F16.9 Unspecified mental and behavioural disorder	0.017	0.983	0.000
F16.8 Other mental and behavioural disorders	0.017	0.983	0.000
F16.7 Residual and late-onset psychotic disorder	0.017	0.983	0.000
F16.6 Amnesic syndrome	0.017	0.983	0.000
F16.5 Psychotic disorder	0.017	0.983	0.000
F16.4 Withdrawal state with delirium	0.017	0.983	0.000
F16.3 Withdrawal state	0.017	0.983	0.000
F16.2 Dependence syndrome	0.017	0.983	0.000
F16.1 Harmful use	0.017	0.983	0.000
F16.0 Acute intoxication	0.017	0.983	0.000
F18.9 Unspecified mental and behavioural disorder	0.017	0.983	0.000
F18.8 Other mental and behavioural disorders	0.017	0.983	0.000
F18.7 Residual and late-onset psychotic disorder	0.017	0.983	0.000
F18.6 Amnesic syndrome	0.017	0.983	0.000
F18.5 Psychotic disorder	0.017	0.983	0.000
F18.4 Withdrawal state with delirium	0.017	0.983	0.000
F18.3 Withdrawal state	0.017	0.983	0.000
F18.2 Dependence syndrome	0.017	0.983	0.000
F18.1 Harmful use	0.017	0.983	0.000
F18.0 Acute intoxication	0.017	0.983	0.000
Chapter IV Endocrine, nutritional and metabolic diseases	0.017	0.983	0.000
E10.5 With peripheral circulatory complications	0.017	0.983	0.000
F15.9 Unspecified mental and behavioural disorder	0.017	0.983	0.000
F15.8 Other mental and behavioural disorders	0.017	0.983	0.000
F15.7 Residual and late-onset psychotic disorder	0.017	0.983	0.000
F15.6 Amnesic syndrome	0.017	0.983	0.000
F15.5 Psychotic disorder	0.017	0.983	0.000
F15.4 Withdrawal state with delirium	0.017	0.983	0.000
F15.3 Withdrawal state	0.017	0.983	0.000
F15.2 Dependence syndrome	0.017	0.983	0.000
F15.0 Acute intoxication	0.017	0.983	0.000
E10.4 With neurological complications	0.017	0.983	0.000
F11.3 Withdrawal state	0.017	0.983	0.000
F14.9 Unspecified mental and behavioural disorder	0.016	0.983	0.000
F14.8 Other mental and behavioural disorders	0.016	0.983	0.000
F14.7 Residual and late-onset psychotic disorder	0.016	0.983	0.000
F14.6 Amnesic syndrome	0.016	0.983	0.000
F14.5 Psychotic disorder	0.016	0.983	0.000
F14.4 Withdrawal state with delirium	0.016	0.983	0.000
F14.3 Withdrawal state	0.016	0.983	0.000
F14.2 Dependence syndrome	0.016	0.983	0.000
F14.0 Acute intoxication	0.016	0.983	0.000
F11.1 Harmful use	0.016	0.983	0.000
H44.2 Degenerative myopia	0.017	0.983	0.000
F11.9 Unspecified mental and behavioural disorder	0.016	0.984	0.000
F11.8 Other mental and behavioural disorders	0.016	0.984	0.000
F11.7 Residual and late-onset psychotic disorder	0.016	0.984	0.000
F11.6 Amnesic syndrome	0.016	0.984	0.000
F11.5 Psychotic disorder	0.016	0.984	0.000
F11.4 Withdrawal state with delirium	0.016	0.984	0.000
F11.0 Acute intoxication	0.016	0.984	0.000
E10.6 With other specified complications	0.016	0.984	0.000
E10.1 With ketoacidosis	0.016	0.984	0.000
F15.1 Harmful use	0.016	0.984	0.000
H43.0 Vitreous prolapse	0.016	0.984	0.000
F19.9 Unspecified mental and behavioural disorder	0.016	0.984	0.000
F19.8 Other mental and behavioural disorders	0.016	0.984	0.000
F19.7 Residual and late-onset psychotic disorder	0.016	0.984	0.000
F19.6 Amnesic syndrome	0.016	0.984	0.000
F19.5 Psychotic disorder	0.016	0.984	0.000
F19.4 Withdrawal state with delirium	0.016	0.984	0.000
F19.3 Withdrawal state	0.016	0.984	0.000
F19.0 Acute intoxication	0.016	0.984	0.000
F14.1 Harmful use	0.016	0.984	0.000
E10-E14 Diabetes mellitus	0.016	0.984	0.000
F19.1 Harmful use	0.015	0.984	0.000
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion	0.015	0.985	0.000
H43.1 Vitreous haemorrhage	0.015	0.985	0.000
M31 Other necrotising vasculopathies	0.015	0.985	0.000
F11.2 Dependence syndrome	0.015	0.985	0.000
F19.2 Dependence syndrome	0.014	0.985	0.000
E10.0 With coma	0.014	0.986	0.000
F13.2 Dependence syndrome	0.014	0.986	0.000
H44.8 Other disorders of globe	0.014	0.986	0.000
E16 Other disorders of pancreatic internal secretion	0.014	0.986	0.000
H44.0 Purulent endophthalmitis	0.014	0.986	0.000
H44.1 Other endophthalmitis	0.014	0.986	0.000
M31.0 Hypersensitivity angiitis	0.013	0.987	0.000
M31.9 Necrotising vasculopathy, unspecified	0.013	0.987	0.000
H45 Disorders of vitreous body and globe in diseases classified elsewhere	0.013	0.987	0.000
M31.4 Aortic arch syndrome [Takayasu]	0.013	0.987	0.000
H44.7 Retained (old) intraocular foreign body, nonmagnetic	0.013	0.987	0.000
H44.9 Disorder of globe, unspecified	0.013	0.987	0.000
H44.6 Retained (old) intraocular foreign body, magnetic	0.013	0.987	0.000
H44.3 Other degenerative disorders of globe	0.013	0.987	0.000
H26.9 Cataract, unspecified	0.012	0.988	0.000
H44.4 Hypotony of eye	0.012	0.988	0.000
E16.0 Drug-induced hypoglycaemia without coma	0.012	0.988	0.000
M31.7 Microscopic polyangiitis	0.012	0.988	0.000
E16.2 Hypoglycaemia, unspecified	0.012	0.988	0.000
M31.8 Other specified necrotising vasculopathies	0.011	0.988	0.000
E16.1 Other hypoglycaemia	0.011	0.988	0.000
E12 Malnutrition-related diabetes mellitus	0.011	0.989	0.000
M31.5 Giant cell arteritis with polymyalgia rheumatica	0.011	0.989	0.000
E15 Nondiabetic hypoglycaemic coma	0.011	0.989	0.000
E10.3 With ophthalmic complications	0.011	0.989	0.000
M31.2 Lethal midline granuloma	0.011	0.989	0.000
E80.4 Gilbert's syndrome	0.011	0.989	0.000
E50-E64 Other nutritional deficiencies	0.011	0.989	0.000
H44.5 Degenerated conditions of globe	0.011	0.989	0.000
M31.1 Thrombotic microangiopathy	0.011	0.989	0.000
E16.9 Disorder of pancreatic internal secretion, unspecified	0.010	0.989	0.000
E16.8 Other specified disorders of pancreatic internal secretion	0.010	0.989	0.000
E16.4 Abnormal secretion of gastrin	0.010	0.989	0.000
E16.3 Increased secretion of glucagon	0.010	0.989	0.000
E40-E46 Malnutrition	0.010	0.990	0.000
M31.6 Other giant cell arteritis	0.010	0.990	0.000
H45.8 Other disorders of vitreous body and globe in diseases classified elsewhere	0.009	0.990	0.000
H45.1 Endophthalmitis in diseases classified elsewhere	0.009	0.990	0.000
H45.0 Vitreous haemorrhage in diseases classified elsewhere	0.009	0.990	0.000
E20-E35 Disorders of other endocrine glands	0.009	0.991	0.000
E53 Deficiency of other B group vitamins	0.009	0.991	0.000
E13 Other specified diabetes mellitus	0.009	0.991	0.000
E20 Hypoparathyroidism	0.009	0.991	0.000
E20.9 Hypoparathyroidism, unspecified	0.009	0.991	0.000
E56 Other vitamin deficiencies	0.008	0.991	0.000
E51 Thiamine deficiency	0.008	0.991	0.000
E12.9 Without complications	0.008	0.992	0.000
E12.8 With unspecified complications	0.008	0.992	0.000
E12.7 With multiple complications	0.008	0.992	0.000
E12.6 With other specified complications	0.008	0.992	0.000
E12.5 With peripheral circulatory complications	0.008	0.992	0.000
E12.4 With neurological complications	0.008	0.992	0.000
E12.3 With ophthalmic complications	0.008	0.992	0.000
E12.2 With renal complications	0.008	0.992	0.000
E12.1 With ketoacidosis	0.008	0.992	0.000
E12.0 With coma	0.008	0.992	0.000
E54 Ascorbic acid deficiency	0.008	0.992	0.000
E58 Dietary calcium deficiency	0.008	0.992	0.000
E64 Sequelae of malnutrition and other nutritional deficiencies	0.008	0.992	0.000
E63 Other nutritional deficiencies	0.008	0.992	0.000
E50 Vitamin A deficiency	0.008	0.992	0.000
E60 Dietary zinc deficiency	0.008	0.992	0.000
E59 Dietary selenium deficiency	0.008	0.992	0.000
E52 Niacin deficiency [pellagra]	0.008	0.992	0.000
E65-E68 Obesity and other hyperalimentation	0.008	0.992	0.000
F17 Mental and behavioural disorders due to use of tobacco	0.008	0.992	0.000
E53.8 Deficiency of other specified B group vitamins	0.008	0.992	0.000
H55 Nystagmus and other irregular eye movements	0.000	0.992	0.008
E44 Protein-energy malnutrition of moderate and mild degree	0.008	0.992	0.000
E45 Retarded development following protein-energy malnutrition	0.008	0.992	0.000
E43 Unspecified severe protein-energy malnutrition	0.008	0.992	0.000
E42 Marasmic kwashiorkor	0.008	0.992	0.000
E41 Nutritional marasmus	0.008	0.992	0.000
E40 Kwashiorkor	0.008	0.992	0.000
E78 Disorders of lipoprotein metabolism and other lipidaemias	0.008	0.992	0.000
C80 Malignant neoplasm without specification of site	0.007	0.993	0.000
E31 Polyglandular dysfunction	0.007	0.993	0.000
E24 Cushing's syndrome	0.007	0.993	0.000
M47.96 Spondylosis, unspecified (Lumbar region)	0.000	0.993	0.007
E55 Vitamin D deficiency	0.007	0.993	0.000
E35 Disorders of endocrine glands in diseases classified elsewhere	0.007	0.993	0.000
E32 Diseases of thymus	0.007	0.993	0.000
E30 Disorders of puberty, not elsewhere classified	0.007	0.993	0.000
E25 Adrenogenital disorders	0.007	0.993	0.000
E22 Hyperfunction of pituitary gland	0.007	0.993	0.000
E34 Other endocrine disorders	0.007	0.993	0.000
E27 Other disorders of adrenal gland	0.007	0.993	0.000
R47.8 Other and unspecified speech disturbances	0.000	0.993	0.007
E14 Unspecified diabetes mellitus	0.007	0.993	0.000
E53.1 Pyridoxine deficiency	0.007	0.993	0.000
E53.0 Riboflavin deficiency	0.007	0.993	0.000
E56.1 Deficiency of vitamin K	0.007	0.993	0.000
E51.2 Wernicke's encephalopathy	0.006	0.993	0.000
E13.8 With unspecified complications	0.006	0.993	0.000
E13.7 With multiple complications	0.006	0.993	0.000
E13.6 With other specified complications	0.006	0.993	0.000
E13.5 With peripheral circulatory complications	0.006	0.993	0.000
E13.4 With neurological complications	0.006	0.993	0.000
E13.2 With renal complications	0.006	0.993	0.000
E13.1 With ketoacidosis	0.006	0.993	0.000
E13.0 With coma	0.006	0.993	0.000
E20.8 Other hypoparathyroidism	0.007	0.993	0.000
E20.1 Pseudohypoparathyroidism	0.007	0.993	0.000
E20.0 Idiopathic hypoparathyroidism	0.007	0.993	0.000
N45.9 Orchitis, epididymitis and epididymo-orchitis without abscess	0.000	0.993	0.007
N83.8 Other noninflammatory disorders of ovary, Fallopian tube and broad ligament	0.000	0.993	0.007
E13.3 With ophthalmic complications	0.006	0.993	0.000
E23 Hypofunction and other disorders of pituitary gland	0.006	0.993	0.000
E56.9 Vitamin deficiency, unspecified	0.006	0.994	0.000
E56.8 Deficiency of other vitamins	0.006	0.994	0.000
E56.0 Deficiency of vitamin E	0.006	0.994	0.000
E53.9 Vitamin B deficiency, unspecified	0.006	0.994	0.000
E51.9 Thiamine deficiency, unspecified	0.006	0.994	0.000
E51.8 Other manifestations of thiamine deficiency	0.006	0.994	0.000
E51.1 Beriberi	0.006	0.994	0.000
E78.8 Other disorders of lipoprotein metabolism	0.006	0.994	0.000
E27.9 Disorder of adrenal gland, unspecified	0.006	0.994	0.000
E26 Hyperaldosteronism	0.006	0.994	0.000
E14.8 With unspecified complications	0.006	0.994	0.000
E78.3 Hyperchylomicronaemia	0.006	0.994	0.000
E50.9 Vitamin A deficiency, unspecified	0.006	0.994	0.000
E50.8 Other manifestations of vitamin A deficiency	0.006	0.994	0.000
E50.7 Other ocular manifestations of vitamin A deficiency	0.006	0.994	0.000
E50.6 Vitamin A deficiency with xerophthalmic scars of cornea	0.006	0.994	0.000
E50.5 Vitamin A deficiency with night blindness	0.006	0.994	0.000
E50.4 Vitamin A deficiency with keratomalacia	0.006	0.994	0.000
E50.3 Vitamin A deficiency with corneal ulceration and xerosis	0.006	0.994	0.000
E50.2 Vitamin A deficiency with corneal xerosis	0.006	0.994	0.000
E50.1 Vitamin A deficiency with Bitot's spot and conjunctival xerosis	0.006	0.994	0.000
E50.0 Vitamin A deficiency with conjunctival xerosis	0.006	0.994	0.000
E63.9 Nutritional deficiency, unspecified	0.006	0.994	0.000
E63.8 Other specified nutritional deficiencies	0.006	0.994	0.000
E63.1 Imbalance of constituents of food intake	0.006	0.994	0.000
E63.0 Essential fatty acid [EFA] deficiency	0.006	0.994	0.000
E64.9 Sequelae of unspecified nutritional deficiency	0.006	0.994	0.000
E64.8 Sequelae of other nutritional deficiencies	0.006	0.994	0.000
E64.3 Sequelae of rickets	0.006	0.994	0.000
E64.2 Sequelae of vitamin C deficiency	0.006	0.994	0.000
E64.1 Sequelae of vitamin A deficiency	0.006	0.994	0.000
E64.0 Sequelae of protein-energy malnutrition	0.006	0.994	0.000
E67 Other hyperalimentation	0.006	0.994	0.000
E68 Sequelae of hyperalimentation	0.006	0.994	0.000
F17.8 Other mental and behavioural disorders	0.006	0.994	0.000
F17.7 Residual and late-onset psychotic disorder	0.006	0.994	0.000
F17.6 Amnesic syndrome	0.006	0.994	0.000
F17.5 Psychotic disorder	0.006	0.994	0.000
F17.4 Withdrawal state with delirium	0.006	0.994	0.000
F17.3 Withdrawal state	0.006	0.994	0.000
F17.0 Acute intoxication	0.006	0.994	0.000
E83.5 Disorders of calcium metabolism	0.006	0.994	0.000
E34.8 Other specified endocrine disorders	0.006	0.994	0.000
E23.6 Other disorders of pituitary gland	0.006	0.994	0.000
F17.9 Unspecified mental and behavioural disorder	0.006	0.994	0.000
E31.0 Autoimmune polyglandular failure	0.006	0.994	0.000
E22.1 Hyperprolactinaemia	0.006	0.994	0.000
E44.1 Mild protein-energy malnutrition	0.006	0.994	0.000
E44.0 Moderate protein-energy malnutrition	0.006	0.994	0.000
E29 Testicular dysfunction	0.006	0.994	0.000
E27.8 Other specified disorders of adrenal gland	0.006	0.994	0.000
E28 Ovarian dysfunction	0.006	0.994	0.000
E22.0 Acromegaly and pituitary gigantism	0.006	0.994	0.000
E24.9 Cushing's syndrome, unspecified	0.006	0.994	0.000
E65 Localised adiposity	0.006	0.994	0.000
E31.9 Polyglandular dysfunction, unspecified	0.005	0.994	0.000
E31.8 Other polyglandular dysfunction	0.005	0.994	0.000
E31.1 Polyglandular hyperfunction	0.005	0.994	0.000
E34.3 Short stature, not elsewhere classified	0.005	0.994	0.000
K51.3 Ulcerative (chronic) rectosigmoiditis	0.006	0.994	0.000
E24.2 Drug-induced Cushing's syndrome	0.005	0.995	0.000
E46 Unspecified protein-energy malnutrition	0.005	0.995	0.000
E24.8 Other Cushing's syndrome	0.005	0.995	0.000
E24.4 Alcohol-induced pseudo-Cushing's syndrome	0.005	0.995	0.000
E24.3 Ectopic ACTH syndrome	0.005	0.995	0.000
E24.1 Nelson's syndrome	0.005	0.995	0.000
E55.0 Rickets, active	0.005	0.995	0.000
Z04.1 Examination and observation following transport accident	0.005	0.995	0.000
E25.9 Adrenogenital disorder, unspecified	0.005	0.995	0.000
E25.8 Other adrenogenital disorders	0.005	0.995	0.000
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency	0.005	0.995	0.000
E30.9 Disorder of puberty, unspecified	0.005	0.995	0.000
E30.8 Other disorders of puberty	0.005	0.995	0.000
E30.1 Precocious puberty	0.005	0.995	0.000
E30.0 Delayed puberty	0.005	0.995	0.000
E32.9 Disease of thymus, unspecified	0.005	0.995	0.000
E32.8 Other diseases of thymus	0.005	0.995	0.000
E32.1 Abscess of thymus	0.005	0.995	0.000
E32.0 Persistent hyperplasia of thymus	0.005	0.995	0.000
E35.8 Disorders of other endocrine glands in diseases classified elsewhere	0.005	0.995	0.000
E35.1 Disorders of adrenal glands in diseases classified elsewhere	0.005	0.995	0.000
E35.0 Disorders of thyroid gland in diseases classified elsewhere	0.005	0.995	0.000
E22.9 Hyperfunction of pituitary gland, unspecified	0.005	0.995	0.000
E22.8 Other hyperfunction of pituitary gland	0.005	0.995	0.000
E27.5 Adrenomedullary hyperfunction	0.005	0.995	0.000
E27.0 Other adrenocortical overactivity	0.005	0.995	0.000
E34.5 Androgen resistance syndrome	0.005	0.995	0.000
E34.4 Constitutional tall stature	0.005	0.995	0.000
E34.2 Ectopic hormone secretion, not elsewhere classified	0.005	0.995	0.000
E34.1 Other hypersecretion of intestinal hormones	0.005	0.995	0.000
E14.6 With other specified complications	0.005	0.995	0.000
E14.4 With neurological complications	0.005	0.995	0.000
E14.7 With multiple complications	0.005	0.995	0.000
E14.0 With coma	0.005	0.995	0.000
E78.4 Other hyperlipidaemia	0.005	0.995	0.000
Z99 Dependence on enabling machines and devices, not elsewhere classified	0.005	0.995	0.000
E24.0 Pituitary-dependent Cushing's disease	0.005	0.995	0.000
E34.0 Carcinoid syndrome	0.005	0.995	0.000
E78.6 Lipoprotein deficiency	0.005	0.995	0.000
E23.7 Disorder of pituitary gland, unspecified	0.005	0.995	0.000
E14.5 With peripheral circulatory complications	0.005	0.995	0.000
E23.3 Hypothalamic dysfunction, not elsewhere classified	0.005	0.995	0.000
E23.1 Drug-induced hypopituitarism	0.005	0.995	0.000
E14.1 With ketoacidosis	0.005	0.995	0.000
E61 Deficiency of other nutrient elements	0.004	0.995	0.001
E23.2 Diabetes insipidus	0.005	0.995	0.000
C80.0 Malignant neoplasm, primary site unknown, so stated	0.005	0.995	0.000
E78.9 Disorder of lipoprotein metabolism, unspecified	0.005	0.995	0.000
E14.2 Withrenal complications	0.005	0.995	0.000
E26.8 Other hyperaldosteronism	0.005	0.995	0.000
E26.1 Secondary hyperaldosteronism	0.005	0.995	0.000
D33.3 Cranial nerves	0.000	0.995	0.005
E27.2 Addisonian crisis	0.005	0.995	0.000
E27.1 Primary adrenocortical insufficiency	0.005	0.995	0.000
N18.0 End-stage renal disease	0.005	0.995	0.000
E67.8 Other specified hyperalimentation	0.004	0.995	0.000
E67.3 Hypervitaminosis D	0.004	0.995	0.000
E67.2 Megavitamin-B6 syndrome	0.004	0.995	0.000
E67.1 Hypercarotenaemia	0.004	0.995	0.000
E67.0 Hypervitaminosis A	0.004	0.995	0.000
E78.2 Mixed hyperlipidaemia	0.005	0.995	0.000
E27.3 Drug-induced adrenocortical insufficiency	0.004	0.995	0.000
D68.8 Other specified coagulation defects	0.000	0.995	0.005
E78.1 Pure hyperglyceridaemia	0.004	0.995	0.000
E26.9 Hyperaldosteronism, unspecified	0.004	0.995	0.000
Z99.0 Dependence on aspirator	0.004	0.996	0.000
E13.9 Without complications	0.004	0.996	0.000
E26.0 Primary hyperaldosteronism	0.004	0.996	0.000
E27.4 Other and unspecified adrenocortical insufficiency	0.004	0.996	0.000
E29.9 Testicular dysfunction, unspecified	0.004	0.996	0.000
E29.8 Other testicular dysfunction	0.004	0.996	0.000
E29.0 Testicular hyperfunction	0.004	0.996	0.000
E28.9 Ovarian dysfunction, unspecified	0.004	0.996	0.000
E28.8 Other ovarian dysfunction	0.004	0.996	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations